Artículos por temáticas

Comparing different types of source memory attributes in dementia of Alzheimer's type

Mammarella N, Fairfield B, Di Domenico A.

Int Psychogeriatr. 2012 Apr;24(4):666-73. doi: 10.1017/S1041610211002274. Epub 2011 Dec 12.

Effects of atorvastatin on cerebral blood flow in middle-aged adults at risk for Alzheimer's disease: a pilot study

Carlsson CM, Xu G, Wen Z, Barnet JH, Blazel HM, Chappell RJ, Stein JH, Asthana S, Sager MA, Alsop DC, Rowley HA, Fain SB, Johnson SC.

Curr Alzheimer Res. 2012 Oct;9(8):990-7. doi: 10.2174/156720512803251075.

Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial

Hanney M, Prasher V, Williams N, Jones EL, Aarsland D, Corbett A, Lawrence D, Yu LM, Tyrer S, Francis PT, Johnson T, Bullock R, Ballard C; MEADOWS trial researchers.

Lancet. 2012 Feb 11;379(9815):528-36. doi: 10.1016/S0140-6736(11)61676-0. Epub 2012 Jan 10.

Schizophrenia or neurodegenerative disease prodrome? Outcome of a first psychotic episode in a 35-year-old woman

Khan BK, Woolley JD, Chao S, See T, Karydas AM, Miller BL, Rankin KP.

Psychosomatics. 2012 May-Jun;53(3):280-4. doi: 10.1016/j.psym.2011.04.005. Epub 2012 Jan 28.

Platelet activation in Alzheimer's disease: from pathophysiology to clinical value

Laske C, Sopova K, Stellos K.

Curr Vasc Pharmacol. 2012 Sep;10(5):626-30. doi: 10.2174/157016112801784657.

[Effects of a psychological group intervention on neuropsychiatric symptoms and communication in Alzheimer's dementia]

Fischer-Terworth C, Probst P.

Z Gerontol Geriatr. 2012 Jul;45(5):392-7. doi: 10.1007/s00391-012-0296-4.

Augmented input reveals word deafness in a man with frontotemporal dementia

Gibbons C, Oken B, Fried-Oken M.

Behav Neurol. 2012;25(2):151-4. doi: 10.3233/BEN-2012-0356.

[Survey of comorbidities for hospitalized patients with cognitive disorders]

Gong WP, Guo QH, Zhao QH, Hong Z.

Zhonghua Yi Xue Za Zhi. 2012 Jan 17;92(3):156-9.

Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer's disease: a meta-analysis

Li FJ, Shen L, Ji HF.

J Alzheimers Dis. 2012;31(2):253-8. doi: 10.3233/JAD-2012-120349.

Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study

Jokinen H, Lipsanen J, Schmidt R, Fazekas F, Gouw AA, van der Flier WM, Barkhof F, Madureira S, Verdelho A, Ferro JM, Wallin A, Pantoni L, Inzitari D, Erkinjuntti T; LADIS Study Group.

Neurology. 2012 May 29;78(22):1785-92. doi: 10.1212/WNL.0b013e3182583070. Epub 2012 May 16.

Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study

Bettermann K, Arnold AM, Williamson J, Rapp S, Sink K, Toole JF, Carlson MC, Yasar S, Dekosky S, Burke GL.

J Stroke Cerebrovasc Dis. 2012 Aug;21(6):436-44. doi: 10.1016/j.jstrokecerebrovasdis.2010.11.002. Epub 2011 Jan 14.

Imaging the default mode network in aging and dementia

Hafkemeijer A, van der Grond J, Rombouts SA.

Biochim Biophys Acta. 2012 Mar;1822(3):431-41. doi: 10.1016/j.bbadis.2011.07.008. Epub 2011 Jul 23.

A case report of daily left prefrontal repetitive transcranial magnetic stimulation (rTMS) as an adjunctive treatment for Alzheimer disease

Haffen E, Chopard G, Pretalli JB, Magnin E, Nicolier M, Monnin J, Galmiche J, Rumbach L, Pazart L, Sechter D, Vandel P.

Brain Stimul. 2012 Jul;5(3):264-266. doi: 10.1016/j.brs.2011.03.003. Epub 2011 Mar 30.

Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer's disease. The Real.FR cohort

Sanz CM, Hanaire H, Vellas BJ, Sinclair AJ, Andrieu S; REAL.FR Study Group.

Diabet Med. 2012 Apr;29(4):541-8. doi: 10.1111/j.1464-5491.2011.03445.x.

Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images

Chu C, Hsu AL, Chou KH, Bandettini P, Lin C; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2012 Mar;60(1):59-70. doi: 10.1016/j.neuroimage.2011.11.066. Epub 2011 Dec 1.